Pet-Ct in Patients With Nоn-Small Cell Lung Cancer: The Use of SUVMax Tо Evaluate the Primary Tumоr and Metastases

Current Trends in Clinical & Medical Imaging
doi 10.19080/ctcmi.2018.02.555597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Juniper Publishers

Related search

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Prognostic Value of SUVmax and Metabolic Tumor Volume on 18f-FDG PET/CT in Early Stage Non-Small Cell Lung Cancer Patients Without LN Metastasis

Bio-Medical Materials and Engineering
MedicineBiomaterialsBiomedical Engineering
2014English

18f-Fet PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non–Small Cell Lung Cancer

Clinical Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2020English

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Letter to the Editor: Increasing PET Use in Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2019English

Clinical Usefulness of 18f-FDG PET/CT for the Detection of Distant Metastases in Patients With Non-Small Cell Lung Cancer at Initial Staging: A Meta-Analysis

Cancer Management and Research
Oncology
2018English

Use of Pet in the Management of Non-Small-Cell Lung Cancer in Canada

Current Oncology
Oncology
2014English

[18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the CONVERT Randomized Controlled Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients With Synchronous Brain Metastases

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy